Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?


Bozkaya Y., Ozdemir N. Y., Sezer S., Kostek O., Demirci N. S., Yazici O., ...More

CANCER BIOMARKERS, vol.22, no.1, pp.143-149, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.3233/cbm-171119
  • Journal Name: CANCER BIOMARKERS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.143-149
  • Keywords: Modified DCF, locally advanced gastric cancer, neoadjuvant chemotherapy, survivin, predictive, ANTI-APOPTOSIS GENE, MESSENGER-RNA, FAVORABLE PROGNOSIS, CISPLATIN TREATMENT, ESOPHAGEAL CANCER, POTENTIAL ROLE, ASSOCIATION, CARCINOMA, THERAPY, PROLIFERATION
  • Gazi University Affiliated: No

Abstract

BACKGROUND: The potential prognostic value of survivin is variably reported depending on the gastric cancer.